Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt RepaymentsNon-Current ReceivablesOther Gross PP&E AdjustmentsReceivables RefundsShares IssuedShort-Term Debt issuances
Ratios

Astrazeneca (AZNCF) Leases (2019 - 2025)

Historic Leases for Astrazeneca (AZNCF) over the last 7 years, with Q4 2025 value amounting to $1.7 billion.

  • Astrazeneca's Leases rose 2480.29% to $1.7 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.7 billion, marking a year-over-year increase of 2480.29%. This contributed to the annual value of $1.7 billion for FY2025, which is 2480.29% up from last year.
  • Per Astrazeneca's latest filing, its Leases stood at $1.7 billion for Q4 2025, which was up 2480.29% from $1.7 billion recorded in Q3 2025.
  • Over the past 5 years, Astrazeneca's Leases peaked at $1.7 billion during Q4 2025, and registered a low of $660.0 million during Q1 2021.
  • Its 5-year average for Leases is $1.1 billion, with a median of $982.5 million in 2021.
  • Per our database at Business Quant, Astrazeneca's Leases surged by 9340.0% in 2021 and then tumbled by 770.04% in 2022.
  • Over the past 5 years, Astrazeneca's Leases (Quarter) stood at $988.0 million in 2021, then decreased by 4.66% to $942.0 million in 2022, then increased by 16.77% to $1.1 billion in 2023, then rose by 26.82% to $1.4 billion in 2024, then increased by 24.8% to $1.7 billion in 2025.
  • Its last three reported values are $1.7 billion in Q4 2025, $1.7 billion for Q3 2025, and $1.6 billion during Q2 2025.